IGF2 derived from SH-SY5Y neuroblastoma cells induces the osteoclastogenesis of human monocytic precursors (Q56984523)

4

0 references

Nicola Baldini

object named as

Nicola Baldini

6

0 references

author name string

Manuela Salerno

2

0 references

Gianni Quacquaruccio

3

0 references

Armando Giunti

Experimental Cell Research

5

0 references

language of work or name

English

0 references

publication date

10 September 2011

0 references

published in

0 references

volume

317

0 references

issue

15

0 references

page(s)

2147-58

0 references

cites work

Mechanisms of bone metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Clinical features of metastatic bone disease and risk of skeletal morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Paracrine inhibition of osteoblast differentiation induced by neuroblastoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Plasma levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in patients with neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Mechanisms of cancer metastasis to the bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Insulin-like growth factor II-mediated proliferation of human neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Insulin-like growth factor-I signaling in human neuroblastoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Growth factor control of bone mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Identification and characterization of the insulin-like growth factor I receptor in mature rabbit osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I: an in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Utilization of activated U937 monocytic cells as a model to evaluate biocompatibility and biodegradation of synthetic calcium phosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Phorbol ester induced osteoclast-like differentiation of a novel human leukemic cell line (FLG 29.1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Role for autocrine TGF-beta 1 in regulating differentiation of a human leukemic cell line toward osteoclast-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Effects of prelamin A processing inhibitors on the differentiation and activity of human osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Characterization of an antibody that can detect an activated IGF-I receptor in human cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Molecular regulation of osteoclast activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Integrins and signaling in osteoclast function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Mechanisms of osteolytic bone metastases in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Insulin-like Growth Factor-II as a Paracrine Growth Factor in Human Neuroblastoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Role of IGF-I signaling in regulating osteoclastogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Insulin-like growth factor-I induces renal cell hypertrophy via a calcineurin-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Cathepsin G recruits osteoclast precursors via proteolytic activation of protease-activated receptor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Macrophage inflammatory protein-1 delta: a novel osteoclast stimulating factor secreted by renal cell carcinoma bone metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030

Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.05.030